Decoding the Lab Reports: Tests and Diagnosis

Diagnosing Laron syndrome involves a series of steps to see how your child’s body produces and responds to growth signals. Because the symptoms can overlap with other growth conditions, doctors use a combination of blood tests, physical examinations, growth velocity, and genetic mapping to confirm the diagnosis.

Deficiency vs. Insensitivity: Understanding the Difference

The most important distinction your pediatric endocrinologist is making is between Growth Hormone Deficiency (GHD) and Growth Hormone Insensitivity (GHI) (Laron syndrome).

• Growth Hormone Deficiency: The brain’s pituitary gland does not make enough growth hormone “keys.” Because there are no keys, the “locks” in the liver never get the signal to grow ^[1].
• Growth Hormone Insensitivity (Laron): The brain makes plenty of growth hormone keys, but the “locks” (receptors) are broken ^[2]. No matter how many keys the body makes, the liver cannot “see” them to start the growth process ^[3].

Lab Report Completeness Checklist

When you look at your child’s lab reports, you will likely see several key markers. For a classic Laron syndrome diagnosis, doctors typically look for this specific pattern ^[4][1]:

1. Low IGF-1: This hormone, which actually does the growing, is almost always very low because the liver isn’t getting the signal to make it ^[5].
2. Low IGFBP-3: This is a “carrier protein” for IGF-1. Since there is very little IGF-1 to carry, this protein level is usually low as well ^[1].
3. Normal to High Growth Hormone (GH): Unlike most growth conditions, GH levels in Laron syndrome are not low. They are often normal or even significantly elevated because the brain is working overtime trying to get a response from the liver ^[1][4].

Important Nuance: A single GH test is not a reliable measure because GH is released in pulses throughout the day, and there is no single universal threshold for GH. Additionally, low IGF-1 and IGFBP-3 are not entirely specific; they can also be caused by malnutrition, thyroid disease, chronic illness, or liver disease ^[6][7]. An endocrinologist must interpret these results along with your child’s growth history and bone age.

The IGF-1 Generation Test

If the initial blood tests suggest Laron syndrome, your doctor may perform an IGF-1 Generation Test. This is used to prove that the body is “insensitive” to growth hormone ^[3].

• The Process: Your child is given daily injections of recombinant Growth Hormone (rhGH) for 4 to 5 days ^[8][9].
• The Goal: Doctors measure IGF-1 levels before the first injection and again on the final day.
• The Result: In a child without Laron syndrome, IGF-1 levels will jump up significantly. In a child with Laron syndrome, the IGF-1 levels will stay very low, showing that the extra growth hormone did not “trigger” the liver to work ^[3][8].

This test is highly protocol-dependent and its necessity is sometimes debated, as nutrition, illness, and puberty can affect the results, so it is rarely used as the only proof of diagnosis ^[6][10].

Confirming with Genetic Testing

To help confirm a Laron syndrome diagnosis, doctors use molecular genetic testing. While a pathogenic result can strongly support the diagnosis, genetic testing has limits and is not a “100% certain” gold standard. A negative genetic test does not completely rule out growth hormone insensitivity.

• GHR Gene Testing: Most classic cases are caused by mutations in the GHR (Growth Hormone Receptor) gene ^[2]. Since this is a “recessive” condition, your child usually needs to have a mutation on both copies of the gene (one from each parent) ^[2].
• What if GHR is Negative?: If your child has all the symptoms but the GHR test is clear, your doctor may order a broader genetic panel or “exome testing” ^[11]. Other genes can “mimic” Laron syndrome by causing problems at different steps of the growth process, such as:
  • STAT5B: Can cause growth failure and immune system issues ^[12].
  • IGF1R: Causes the body to be insensitive to IGF-1 itself ^[13].
  • PAPPA2: Impairs the cleavage of IGFBP-3/5, reducing the amount of bioavailable (free) IGF-1 ^[13].

Identifying the specific gene mutation helps clarify the diagnosis and guides genetic counseling for your family, but the final diagnosis always combines clinical, growth, biochemical, and genetic evidence ^[13][10].